Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
Title:
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
Author:
Slovin, Susan F. Ragupathi, Govind Musselli, Cristina Fernandez, Celina Diani, Meghan Verbel, David Danishefsky, Samuel Livingston, Philip Scher, Howard I.